PMV Pharmaceuticals, Inc.

The momentum for this stock is not very good. PMV Pharmaceuticals, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in PMV Pharmaceuticals, Inc..
Log in to see more information.

News

Assenagon Asset Management S.A. Boosts Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
Assenagon Asset Management S.A. Boosts Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

Ticker Report Assenagon Asset Management S.A. raised its holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP - Free Report) by 267.2% during the 2nd quarter, according to its most recent disclosure with the...\n more…

PMV Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.35) Per Share, HC Wainwright Forecasts (NASDAQ:PMVP)
PMV Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.35) Per Share, HC Wainwright Forecasts (NASDAQ:PMVP)

Ticker Report PMV Pharmaceuticals, Inc. (NASDAQ:PMVP - Free Report) - Research analysts at HC Wainwright cut their Q3 2024 earnings per share (EPS) estimates for PMV Pharmaceuticals in a research note issued on...\n more…

PMV Pharmaceuticals (NASDAQ:PMVP) Receives "Buy" Rating from HC Wainwright
PMV Pharmaceuticals (NASDAQ:PMVP) Receives "Buy" Rating from HC Wainwright

Ticker Report HC Wainwright restated their buy rating on shares of PMV Pharmaceuticals (NASDAQ:PMVP - Free Report) in a report published on Tuesday, Benzinga reports. The brokerage currently has a $5.00 price...\n more…

PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial
PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial

Globe Newswire Enrollment on track in Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 60% of sites...\n more…

Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans?
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans?

Simply Wall St There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...\n more…

Mirae Asset Global Investments Co. Ltd. Acquires Shares of 15,492 PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
Mirae Asset Global Investments Co. Ltd. Acquires Shares of 15,492 PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

Zolmax Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP - Free Report) in the first quarter, according to its most recent filing with the...\n more…